SACHEM Release New Advanced Ceramic Nanopowder Produced by Novel Precipitating Agent

SACHEM is expanding its Avanta AC(TM) product line by offering a new precipitating agent, Avanta AC(TM) 4210.

The new product is featured in a white paper titled, “Novel Oxalate Precursors for Mixed Metal Oxide Synthesis.” The white paper outlines the use of standard precipitating agents in solution-based synthesis methods, as well as processing performance benefits possible with the new Avanta ACTM 4210 Advanced Ceramics Precipitating Agent.

Advanced ceramic nanopowders are critical to a variety of leading edge technology applications, ranging from electronics, superconductors, transparent conductive coatings and inorganic membranes for fuel cells. SACHEM’s Avanta AC™ 4210 Advanced Precipitating Agent has been found to exhibit higher performance and improved processing characteristics.

Mark Stasney, Electronics Market Manager at SACHEM, says “The use of new oxalate raw materials brings significant advantages over ammonium oxalate, whether formed in-situ or added as ammonium oxalate. SACHEM’s Avanta AC™ Advanced Precipitating Agent combines the best attributes of ammonium oxalate with increased solubility of the oxalate solution in water, a wider pH operating range and the potential to reduce emissions."

SACHEM, Inc. delivers highly pure, precise and innovative chemical solutions designed to solve the most demanding and challenging applications. For over 50 years SACHEM has provided chemical solutions and services to customers in key markets including electronics, biotechnology, starch modification, polymers, catalysts, pharmaceutical and agricultural chemicals. Based in Austin, Texas, SACHEM's expanding worldwide operations include manufacturing and research facilities in North America, Europe and Asia with a global service network and presence spanning over 30 countries. For more information, please visit www.sacheminc.com.


For more information on ceramic, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.